Modern Interventional Treatments for Meibomian Gland Dysfunction

In this episode, Douglas K. Devries, OD, and Hardeep Kataria, OD, FAAO, discuss some findings from the Interventional Meibomian Gland Dysfunction (MGD) Consensus, namely those related to the use of modern interventional MGD treatments. Moreover, Drs. Devries and Kataria review various palliative and prescription MGD treatment options and discuss how interventional MGD treatments differ from more conventional treatments. The faculty also discuss the importance of patient education when incorporating interventional MGD treatments into a standard clinical practice. This independent educational activity is supported by unrestricted educational grants from Alcon, Johnson & Johnson Vision, and Sight Sciences.